Cargando…

Viral Vaccines

Since antiquity, humans have strived to find ways to prevent the suffering and mortality caused by infectious pathogens. No interventions in medical history have had a bigger impact on human health than the development of preventative vaccines against infectious diseases. Viruses represent important...

Descripción completa

Detalles Bibliográficos
Autor principal: Schleiss, M.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830773/
http://dx.doi.org/10.1016/B978-0-12-818731-9.00225-1
_version_ 1784648346837712896
author Schleiss, M.R.
author_facet Schleiss, M.R.
author_sort Schleiss, M.R.
collection PubMed
description Since antiquity, humans have strived to find ways to prevent the suffering and mortality caused by infectious pathogens. No interventions in medical history have had a bigger impact on human health than the development of preventative vaccines against infectious diseases. Viruses represent important pathogens responsible for epidemics and, in the case of influenza and SARS-CoV-2, global pandemics responsible for substantial - and sometimes staggering - morbidity and mortality. This article reviews the viral vaccines used today in clinical practice, summarizes the differences in vaccine design and manufacturing, and identifies priorities for future research and development of new viral vaccines.
format Online
Article
Text
id pubmed-8830773
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-88307732022-02-11 Viral Vaccines Schleiss, M.R. Encyclopedia of Infection and Immunity Article Since antiquity, humans have strived to find ways to prevent the suffering and mortality caused by infectious pathogens. No interventions in medical history have had a bigger impact on human health than the development of preventative vaccines against infectious diseases. Viruses represent important pathogens responsible for epidemics and, in the case of influenza and SARS-CoV-2, global pandemics responsible for substantial - and sometimes staggering - morbidity and mortality. This article reviews the viral vaccines used today in clinical practice, summarizes the differences in vaccine design and manufacturing, and identifies priorities for future research and development of new viral vaccines. 2022 2022-04-08 /pmc/articles/PMC8830773/ http://dx.doi.org/10.1016/B978-0-12-818731-9.00225-1 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Schleiss, M.R.
Viral Vaccines
title Viral Vaccines
title_full Viral Vaccines
title_fullStr Viral Vaccines
title_full_unstemmed Viral Vaccines
title_short Viral Vaccines
title_sort viral vaccines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830773/
http://dx.doi.org/10.1016/B978-0-12-818731-9.00225-1
work_keys_str_mv AT schleissmr viralvaccines